About
NGM Bio is a clinical-stage biopharmaceutical company developing first-in-class biologic medicines targeting human biology pathways, including treatments for hyperemesis gravidarum and cancer cachexia.
Explore NGM Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.